Rationale and design of the first randomized, double-blind, placebo-controlled trial of intramyocardial injection of autologous bone-marrow derived Mesenchymal Stromal Cells in chronic ischemic Heart Failure (MSC-HF Trial)
2012 ◽
Vol 164
(3)
◽
pp. 285-291
◽
2009 ◽
Vol 15
(10)
◽
pp. 828-834
◽
2016 ◽
pp. 111-116
2018 ◽
Vol 29
(4)
◽
pp. S3-S4
2003 ◽
Vol 107
(18)
◽
pp. 2294-2302
◽
2014 ◽
Vol 7
(6)
◽
pp. 545-552
◽
2014 ◽
Vol 33
(6)
◽
pp. 567-574
◽
2013 ◽
Vol 34
(suppl 1)
◽
pp. 3554-3554
◽